每个QALY估计的边际成本:它们有什么好处?
Chris Sampson1, Graham Cookson1
1Office of Health Economics, 2nd Floor Goldings House, Hay's Galleria, 2 Hay's Lane, London, SE1 2HB, United Kingdom.
Health policy (Amsterdam, Netherlands)
|March 6, 2024
概括
每个质量调整寿命年 (MCPQ) 的边际成本估计被广泛使用,但往往被误解. 该评论认为,目前的证据不支持有关过去绩效或未来决策的说法,这表明MCPQ应该关注支出后果.
科学领域:
- 卫生经济学 卫生经济学
- 卫生政策分析 卫生政策分析
- 成本效益研究 成本效益研究
背景情况:
- 在全球医疗保健系统中,估计每年质量调整后生命年 (MCPQ) 的边际成本普遍存在.
- 研究人员经常解释MCPQ估计,以指导卫生政策决策.
- 最近的一篇健康政策文章作为一个案例研究来检查这些解释.
研究的目的:
- 在卫生政策中批判性地评估有关MCPQ估计的说法.
- 评估支持有关过去医疗服务绩效和未来决策的主张的证据.
- 建议在政策讨论中更适当地应用MCPQ估计.
主要方法:
- 对现有研究和声称的评论和批判性分析.
- 使用健康政策中的特定文章进行案例研究方法.
- 检查影响索赔的因素,包括生产力,技术,门和预算分配.
主要成果:
- 提出的证据并不能充分证明有关MCPQ估计的说法.
- 现有的解释往往过度地适用于过去的业绩和未来的政策.
- 评论强调了证据与得出的结论之间的脱节.
结论:
- 不应使用MCPQ估计来证明有关过去医疗服务业绩的说法或决定未来的政策决策.
- 证据不支持使用MCPQ来评估生产力,技术影响或预算分配.
- 为了更好地了解医疗保健支出变化的后果,MCPQ估计更适合使用.
相关概念视频
Detection of Gross Error: The Q Test
6.1K
When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
6.1K
Kaplan-Meier Approach
137
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
137
Quartile
4.2K
Quartiles are numbers that separate the data into quarters. Quartiles may or may not be part of the data. To find the quartiles, first, find the median or second quartile. The first quartile, Q1, is the middle value of the lower half of the data, and the third quartile, Q3, is the middle value, or median, of the upper half of the data. To get the idea, consider the same data set:
1; 1; 2; 2; 4; 6; 6.8; 7.2; 8; 8.3; 9; 10; 10; 11.5
The median or second quartile is seven. The lower half of the...
1; 1; 2; 2; 4; 6; 6.8; 7.2; 8; 8.3; 9; 10; 10; 11.5
The median or second quartile is seven. The lower half of the...
4.2K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
498
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
498


